ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-invasive Parenteral Screening Instruments Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-19G753
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non invasive Parenteral Screening Instruments Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-invasive Parenteral Screening Instruments Market Insights, Forecast to 2030

Code: QYRE-Auto-19G753
Report
December 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GE Healthcare
Philips
Illumina Inc
Thermo Fisher Scientific
Roche
PacBio
PerkinElmer Inc
Qiagen NV
Agilent Technologies
BGI Group

Non-invasive Parenteral Screening Instruments Market Size

The global Non-invasive Parenteral Screening Instruments market is projected to grow from US$ 4178 million in 2024 to US$ 7241.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period.

Non-invasive Parenteral Screening Instruments Market

Non-invasive Parenteral Screening Instruments Market

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
Market Analysis and Insights: Global Non-invasive Parenteral Screening Instruments Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Non-invasive Parenteral Screening Instruments market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Non-invasive Parenteral Screening Instruments, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-invasive Parenteral Screening Instruments, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-invasive Parenteral Screening Instruments revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-invasive Parenteral Screening Instruments market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-invasive Parenteral Screening Instruments revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Non-invasive Parenteral Screening Instruments Market Report

Report Metric Details
Report Name Non-invasive Parenteral Screening Instruments Market
Accounted market size in 2024 US$ 4178 million
Forecasted market size in 2030 US$ 7241.6 million
CAGR 9.6
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Non-invasive Parenteral Screening Instruments in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non-invasive Parenteral Screening Instruments companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-invasive Parenteral Screening Instruments revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Non-invasive Parenteral Screening Instruments Market growing?

Ans: The Non-invasive Parenteral Screening Instruments Market witnessing a CAGR of 9.6 during the forecast period 2025-2030.

What is the Non-invasive Parenteral Screening Instruments Market size in 2030?

Ans: The Non-invasive Parenteral Screening Instruments Market size in 2030 will be US$ 7241.6 million.

Who are the main players in the Non-invasive Parenteral Screening Instruments Market report?

Ans: The main players in the Non-invasive Parenteral Screening Instruments Market are GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group

What are the Application segmentation covered in the Non-invasive Parenteral Screening Instruments Market report?

Ans: The Applications covered in the Non-invasive Parenteral Screening Instruments Market report are Diagnostic Laboratories, Hospitals

What are the Type segmentation covered in the Non-invasive Parenteral Screening Instruments Market report?

Ans: The Types covered in the Non-invasive Parenteral Screening Instruments Market report are Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Others

Recommended Reports

Prenatal Screening & Diagnostics

Diagnostic Instruments & Systems

Genetic Testing & Cancer

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ultrasound Devices
1.2.3 Next-Generation Sequencing Systems
1.2.4 Polymerase Chain Reaction Instruments
1.2.5 Microarrays
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive Parenteral Screening Instruments Market Perspective (2019-2030)
2.2 Global Non-invasive Parenteral Screening Instruments Growth Trends by Region
2.2.1 Non-invasive Parenteral Screening Instruments Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-invasive Parenteral Screening Instruments Historic Market Size by Region (2019-2024)
2.2.3 Non-invasive Parenteral Screening Instruments Forecasted Market Size by Region (2025-2030)
2.3 Non-invasive Parenteral Screening Instruments Market Dynamics
2.3.1 Non-invasive Parenteral Screening Instruments Industry Trends
2.3.2 Non-invasive Parenteral Screening Instruments Market Drivers
2.3.3 Non-invasive Parenteral Screening Instruments Market Challenges
2.3.4 Non-invasive Parenteral Screening Instruments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Non-invasive Parenteral Screening Instruments by Players
3.1.1 Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024)
3.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Players (2019-2024)
3.2 Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Non-invasive Parenteral Screening Instruments, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio
3.4.1 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Instruments Revenue in 2023
3.5 Global Key Players of Non-invasive Parenteral Screening Instruments Head office and Area Served
3.6 Global Key Players of Non-invasive Parenteral Screening Instruments, Product and Application
3.7 Global Key Players of Non-invasive Parenteral Screening Instruments, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Parenteral Screening Instruments Breakdown Data by Type
4.1 Global Non-invasive Parenteral Screening Instruments Historic Market Size by Type (2019-2024)
4.2 Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Type (2025-2030)
5 Non-invasive Parenteral Screening Instruments Breakdown Data by Application
5.1 Global Non-invasive Parenteral Screening Instruments Historic Market Size by Application (2019-2024)
5.2 Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-invasive Parenteral Screening Instruments Market Size (2019-2030)
6.2 North America Non-invasive Parenteral Screening Instruments Market Size by Type
6.2.1 North America Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
6.2.2 North America Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030)
6.2.3 North America Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
6.3 North America Non-invasive Parenteral Screening Instruments Market Size by Application
6.3.1 North America Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
6.3.2 North America Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030)
6.3.3 North America Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
6.4 North America Non-invasive Parenteral Screening Instruments Market Size by Country
6.4.1 North America Non-invasive Parenteral Screening Instruments Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)
6.4.3 North America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Non-invasive Parenteral Screening Instruments Market Size (2019-2030)
7.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Type
7.2.1 Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
7.2.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030)
7.2.3 Europe Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Application
7.3.1 Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
7.3.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030)
7.3.3 Europe Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
7.4 Europe Non-invasive Parenteral Screening Instruments Market Size by Country
7.4.1 Europe Non-invasive Parenteral Screening Instruments Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)
7.4.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Non-invasive Parenteral Screening Instruments Market Size (2019-2030)
8.2 China Non-invasive Parenteral Screening Instruments Market Size by Type
8.2.1 China Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
8.2.2 China Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030)
8.2.3 China Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
8.3 China Non-invasive Parenteral Screening Instruments Market Size by Application
8.3.1 China Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
8.3.2 China Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030)
8.3.3 China Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Non-invasive Parenteral Screening Instruments Market Size (2019-2030)
9.2 Asia Non-invasive Parenteral Screening Instruments Market Size by Type
9.2.1 Asia Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
9.2.2 Asia Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030)
9.2.3 Asia Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
9.3 Asia Non-invasive Parenteral Screening Instruments Market Size by Application
9.3.1 Asia Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
9.3.2 Asia Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030)
9.3.3 Asia Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
9.4 Asia Non-invasive Parenteral Screening Instruments Market Size by Region
9.4.1 Asia Non-invasive Parenteral Screening Instruments Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024)
9.4.3 Asia Non-invasive Parenteral Screening Instruments Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Type
10.2.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Application
10.3.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Country
10.4.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Introduction
11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.1.5 GE Healthcare Recent Developments
11.2 Philips
11.2.1 Philips Company Details
11.2.2 Philips Business Overview
11.2.3 Philips Non-invasive Parenteral Screening Instruments Introduction
11.2.4 Philips Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.2.5 Philips Recent Developments
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Non-invasive Parenteral Screening Instruments Introduction
11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.3.5 Illumina Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Introduction
11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Non-invasive Parenteral Screening Instruments Introduction
11.5.4 Roche Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 PacBio
11.6.1 PacBio Company Details
11.6.2 PacBio Business Overview
11.6.3 PacBio Non-invasive Parenteral Screening Instruments Introduction
11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.6.5 PacBio Recent Developments
11.7 Perkinelmer
11.7.1 Perkinelmer Company Details
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Introduction
11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.7.5 Perkinelmer Recent Developments
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Introduction
11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.8.5 Qiagen Recent Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Introduction
11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.9.5 Agilent Technologies Recent Developments
11.10 BGI Group
11.10.1 BGI Group Company Details
11.10.2 BGI Group Business Overview
11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Introduction
11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)
11.10.5 BGI Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
GE Healthcare
Philips
Illumina Inc
Thermo Fisher Scientific
Roche
PacBio
PerkinElmer Inc
Qiagen NV
Agilent Technologies
BGI Group
List of Tables
    Table 1. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Ultrasound Devices
    Table 3. Key Players of Next-Generation Sequencing Systems
    Table 4. Key Players of Polymerase Chain Reaction Instruments
    Table 5. Key Players of Microarrays
    Table 6. Key Players of Others
    Table 7. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Non-invasive Parenteral Screening Instruments Market Share by Region (2019-2024)
    Table 11. Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Non-invasive Parenteral Screening Instruments Market Share by Region (2025-2030)
    Table 13. Non-invasive Parenteral Screening Instruments Market Trends
    Table 14. Non-invasive Parenteral Screening Instruments Market Drivers
    Table 15. Non-invasive Parenteral Screening Instruments Market Challenges
    Table 16. Non-invasive Parenteral Screening Instruments Market Restraints
    Table 17. Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Non-invasive Parenteral Screening Instruments Revenue Share by Players (2019-2024)
    Table 19. Global Top Non-invasive Parenteral Screening Instruments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2023)
    Table 20. Global Non-invasive Parenteral Screening Instruments Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Instruments Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Non-invasive Parenteral Screening Instruments, Headquarters and Area Served
    Table 23. Global Key Players of Non-invasive Parenteral Screening Instruments, Product and Application
    Table 24. Global Key Players of Non-invasive Parenteral Screening Instruments, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2019-2024)
    Table 28. Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2025-2030)
    Table 30. Global Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2019-2024)
    Table 32. Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2025-2030)
    Table 34. North America Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Non-invasive Parenteral Screening Instruments Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Non-invasive Parenteral Screening Instruments Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Non-invasive Parenteral Screening Instruments Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Non-invasive Parenteral Screening Instruments Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)
    Table 66. GE Healthcare Company Details
    Table 67. GE Healthcare Business Overview
    Table 68. GE Healthcare Non-invasive Parenteral Screening Instruments Product
    Table 69. GE Healthcare Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 70. GE Healthcare Recent Developments
    Table 71. Philips Company Details
    Table 72. Philips Business Overview
    Table 73. Philips Non-invasive Parenteral Screening Instruments Product
    Table 74. Philips Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 75. Philips Recent Developments
    Table 76. Illumina Company Details
    Table 77. Illumina Business Overview
    Table 78. Illumina Non-invasive Parenteral Screening Instruments Product
    Table 79. Illumina Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 80. Illumina Recent Developments
    Table 81. Thermo Fisher Scientific Company Details
    Table 82. Thermo Fisher Scientific Business Overview
    Table 83. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product
    Table 84. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 85. Thermo Fisher Scientific Recent Developments
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Non-invasive Parenteral Screening Instruments Product
    Table 89. Roche Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 90. Roche Recent Developments
    Table 91. PacBio Company Details
    Table 92. PacBio Business Overview
    Table 93. PacBio Non-invasive Parenteral Screening Instruments Product
    Table 94. PacBio Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 95. PacBio Recent Developments
    Table 96. Perkinelmer Company Details
    Table 97. Perkinelmer Business Overview
    Table 98. Perkinelmer Non-invasive Parenteral Screening Instruments Product
    Table 99. Perkinelmer Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 100. Perkinelmer Recent Developments
    Table 101. Qiagen Company Details
    Table 102. Qiagen Business Overview
    Table 103. Qiagen Non-invasive Parenteral Screening Instruments Product
    Table 104. Qiagen Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 105. Qiagen Recent Developments
    Table 106. Agilent Technologies Company Details
    Table 107. Agilent Technologies Business Overview
    Table 108. Agilent Technologies Non-invasive Parenteral Screening Instruments Product
    Table 109. Agilent Technologies Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 110. Agilent Technologies Recent Developments
    Table 111. BGI Group Company Details
    Table 112. BGI Group Business Overview
    Table 113. BGI Group Non-invasive Parenteral Screening Instruments Product
    Table 114. BGI Group Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)
    Table 115. BGI Group Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Non-invasive Parenteral Screening Instruments Market Share by Type: 2023 VS 2030
    Figure 3. Ultrasound Devices Features
    Figure 4. Next-Generation Sequencing Systems Features
    Figure 5. Polymerase Chain Reaction Instruments Features
    Figure 6. Microarrays Features
    Figure 7. Others Features
    Figure 8. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Non-invasive Parenteral Screening Instruments Market Share by Application: 2023 VS 2030
    Figure 10. Diagnostic Laboratories Case Studies
    Figure 11. Hospitals Case Studies
    Figure 12. Non-invasive Parenteral Screening Instruments Report Years Considered
    Figure 13. Global Non-invasive Parenteral Screening Instruments Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Non-invasive Parenteral Screening Instruments Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Non-invasive Parenteral Screening Instruments Market Share by Region: 2023 VS 2030
    Figure 16. Global Non-invasive Parenteral Screening Instruments Market Share by Players in 2023
    Figure 17. Global Top Non-invasive Parenteral Screening Instruments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Instruments Revenue in 2023
    Figure 19. North America Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
    Figure 21. North America Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
    Figure 22. North America Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)
    Figure 23. United States Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Non-invasive Parenteral Screening Instruments Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
    Figure 27. Europe Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
    Figure 28. Europe Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)
    Figure 29. Germany Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Non-invasive Parenteral Screening Instruments Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
    Figure 37. China Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
    Figure 38. Asia Non-invasive Parenteral Screening Instruments Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
    Figure 40. Asia Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
    Figure 41. Asia Non-invasive Parenteral Screening Instruments Market Share by Region (2019-2030)
    Figure 42. Japan Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)
    Figure 52. Brazil Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 59. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 60. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 62. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 63. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 64. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 65. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 66. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 67. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Non invasive Parenteral Screening Market Insights Forecast to 2030
Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030
Global Non Invasive Prenatal Screening NIPS Market Research Report 2024
Global NIPT NIPS Testing Service Market Research Report 2024
Non invasive Prenatal Testing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Noninvasive Prenatal Testing Service Market Research Report 2025
Global Microarray based Non Invasive Prenatal Testing Market Research Report 2024
Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024
Global Non Invasive Prenatal Testing NIPT Market Research Report 2024
Non Invasive Prenatal Testing Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prenatal Genetic Screening Test Market Research Report 2024
Global Non invasive Preimplantation Genetic Testing Market Research Report 2024
Global Non invasive Fetal and Maternal Monitoring Devices Market Research Report 2024
Neonatal Screening Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Prenatal Paternity Testing NIPPT Market Research Report 2024
Medical Newborn Screening Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Newborn Screening Instruments Market Insights Forecast to 2030
Prenatal Testing and Newborn Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions